Position in FTRE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$31,071,122
-$20,472,927 QoQ
Shares Held
3,298,421
+10.4% QoQ
Ownership
3.49%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 96.48992654364012.ToString("F0")%
Shared 0.ToString("F0")%
None 3.5100734563598768.ToString("F0")%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $4,606,642,545 across 213 Biotechnology names. FTRE ranks #14 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,231,008 | $951,126,014 | |
| 2 | EXEL |
Exelixis, Inc.
|
13,095,741 | $561,676,326 | |
| 3 | INCY |
Incyte Corp
|
5,807,930 | $546,642,368 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,676,541 | $433,647,798 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
913,104 | $302,118,715 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,338,458 | $253,035,481 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,782,038 | $181,424,357 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,946,858 | $164,727,963 |
All Filings in FTRE
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,071,122 | 3,298,421 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $51,544,049 | 2,988,061 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $31,452,765 | 3,735,483 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $32,184,711 | 6,515,124 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $8,269,376 | 1,095,282 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $7,245,580 | 388,503 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $6,286,560 | 314,328 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,361,916 | 144,041 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $9,410,541 | 234,443 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $13,397,446 | 383,881 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $3,953,510 | 138,283 | Shares | Other | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||